HPV-Targeted Drug Sets Survival Mark in Cervical Cancer
MedPage Today,
NATIONAL HARBOR, Md. -- Treatment with a human papillomavirus (HPV)-targeting immunotherapy resulted in the highest-ever 12-month…
The development and use of vascular targeted therapy in ovarian cancer
Overview of attention for article published in Gynecologic Oncology, February 2017
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (82nd percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Readers on
- mendeley
- 67 Mendeley